期刊文献+

膀胱癌组织中端粒酶活性的检测及其意义 被引量:3

Study of Telomerase Activity in Bladder Carcinoma
下载PDF
导出
摘要 目的 研究端粒酶与膀胱移行细胞癌 (TCC)生物学行为的关系。方法 采用端粒酶重复序列扩增法及酶联免疫吸附法检测 5 8例TCC组织、10例癌旁膀胱粘膜及 10例正常膀胱粘膜组织的端粒酶活性。结果 TCC组织端粒酶阳性率为 86 .2 %(5 0 / 5 8) ,不同病理分级、临床分期之间无显著性差异 (P >0 .0 5 ) ;癌旁组织中只有 1例端粒酶阳性 ;正常组织中端粒酶均为阴性。结论 TCC组织中端粒酶活性阳性率明显高于正常膀胱粘膜组织及癌旁膀胱粘膜组织。各病理分级和临床分期之间端粒酶活性虽然无显著性差异 (P >0 .0 5 ) ,但端粒酶活性的强弱分布不同。端粒酶活性可作为TCC早期诊断。 Objective To study the telomerase activity in bladder transitional cell carcinoma(TCC) and its relationship to the biological malignant potentials of TCC.Methods The Telomerase activity was examined by TRAP ELISA in 58 cases of TCC,10 cases of the adjacent tissues and 10 cases of normal bladder tissues.Results Telomerase activity was found in 50(86.2%)of 58 bladder tumor samples,1(10.0%) of 10 adjacent tissues and none of 10 normal bladder tissues,the positive rate of telomerase activity in TCC was significantly higher than that in the adjacent tissues and normal bladder tissues( P <0.01).But unexpectedly,no significant correlation was observed between the positive rate of telomerase activity and the clinicopathologic features,including pathologic grade and clinical stage( P >0.05).Conclusion Telomerase activition may be a critical step in the pathogenesis of TCC.Telomerase activity is a useful marker for detecting TCC and predicting recurrence of TCC.
出处 《实用癌症杂志》 2001年第3期228-230,共3页 The Practical Journal of Cancer
基金 广东省医学科学技术研究基金资助!(No .A 1 999468)
关键词 膀胱肿瘤 端粒酶活性 膀胱癌 端粒重复序列增生 诊断 Bladder neoplasms Telomerase Carcinoma
  • 相关文献

参考文献1

二级参考文献5

共引文献7

同被引文献18

  • 1胡华成.纤支镜肺活检对肺部疾病173例诊断结果[J].中华内科杂志,1995,893(1):4-4.
  • 2姚世昌 蔡柏蔷.肺癌的生物学标志.呼吸内科分册(第1版)[M].北京:中国协和医科大学出版社,2000.791-799.
  • 3SHAMMAS M A,SHMOOKLERR REIS R J.AKIYAMA M,et al.Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma[J].Mol Cancer Ther,2003,2(9):825-833.
  • 4CUESTA J,READ M A,NEIDLE S.The design of G-q-uadruplex ligands as telomerase inhibitors[J].Mini Rev MedChem,2003,3(1):11-21.
  • 5IZBICKA E.WHEELHOUSE R T.RAYMOND E,et al.Effects of cationic porphyrins asG-quabruplex interactive agents in human tumor cells[J].Cancer Res,1999,59 (3):639-644.
  • 6TIMUR I,GAYNUTDINOV,RONALD D,et al.Struc tural polymorphism of intramolecular quadruplex of human telomeric DNA:effect of cations,quadruplex-binding drugs and flanking.Sequences[J].Nucleic Acids Res,2008,36(12):4079-4087.
  • 7WU K J,GRANDORI C,AMACKERMET,et al.Directactivation of TERT transcription by c-myc[J].Nat Genet,1999,21(2):220-224.
  • 8GRAND C L,HAM H.MUNOZ R M,et al.The cationic porphyrin TMPyP4 down-regulates c-myc and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo[J].Mol Cancer Therap,2002,1 (8).-565-573.
  • 9LEMARTELEUR T,GOMEZD,PATERSKI R,et al.Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase[J].Biophys Res Commun,2004,323(3):802-808.
  • 10Naasani I, Oh-Hashi F, Oh-Hara T, et al. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo [J]. Cancer Res, 2003,63(4):824-830.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部